Westpac Banking Corp’s Meridian Bioscience Inc VIVO Stock Holding History

Westpac Banking Corp’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-195,000	Closed	-$4M	–	923
2015 Q4	$4M	Hold	195,000	–	–	0.04%	344
2015 Q3	$3.33M	Hold	195,000	–	–	0.04%	374
2015 Q2	$3.63M	Sell	195,000 -19,800	-9%	-$367K	0.04%	357
2015 Q1	$4.1M	Buy	214,800 +147,400	+219%	+$2.73M	0.04%	403
2014 Q4	$1.11M	Sell	67,400 -12,200	-15%	-$209K	0.01%	594
2014 Q3	$1.41M	Hold	79,600	–	–	0.01%	548
2014 Q2	$1.64M	Sell	79,600 -18,300	-19%	-$376K	0.02%	535
2014 Q1	$2.13M	Hold	97,900	–	–	0.02%	468
2013 Q4	$2.6M	Sell	97,900 -40,600	-29%	-$998K	0.03%	434
2013 Q3	$3.28M	Buy	138,500 +137,500	+13,750%	+$3.21M	0.04%	361
2013 Q2	$22.8K	Buy	+1,000	New	+$21.6K	﹤0.01%	950

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Westpac Banking Corp's VIVO Position: Q1 2016 in Review

Westpac Banking Corp sold out of Meridian Bioscience Inc (VIVO) in Q1 2016, closing a stake of 195,000 shares — an estimated $4M sold.

Westpac Banking Corp first reported a position in VIVO in Q2 2013 and held it in 11 quarters. The position peaked at $4.1M in Q1 2015. 172 funds tracked by Wall St. Rank hold VIVO as of Q1 2016.

Westpac Banking Corp reported no remaining Meridian Bioscience Inc position as of Q1 2016 after selling out during the quarter.
Westpac Banking Corp sold 195,000 Meridian Bioscience Inc shares in Q1 2016, an estimated $4M.
Westpac Banking Corp first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 11 quarters.
Westpac Banking Corp's Meridian Bioscience Inc position peaked at $4.1M in Q1 2015.
172 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2016.

Based on Westpac Banking Corp's 13F filing for Q1 2016, filed 13 May 2016.